option chains Fidelity
Home > Boards > US Listed > Biotechs >

Inovio Biomedical Corp. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator subslover, pistol1p, jagsrocknfl, biovalidator
Search This Board:
Last Post: 4/23/2014 3:26:01 PM - Followers: 384 - Board type: Free - Posts Today: 1

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#11537   This board has been pretty quiet lately. Limp biscuit 04/23/14 03:26:01 PM
#11536   Buy now. ElChico 04/22/14 10:00:47 PM
#11535   Melanoma is very interesting and I'm thinking about DrBob99 04/21/14 03:40:57 PM
#11534   Thank you---I have both INO and ONCS at north40000 04/21/14 02:54:21 PM
#11533   Abstracts will be published on the ASCO.org website DrBob99 04/21/14 02:46:23 PM
#11532   ASCO presentation titles and schedules are now available north40000 04/21/14 02:32:07 PM
#11531   iplanner.asco.org/am2014 This is the ASCO planner site. DrBob99 04/21/14 01:22:23 PM
#11530   Where did you find this, as don't see James salmon 04/21/14 11:49:03 AM
#11529   INO ASCO Abstract - DrBob99 04/21/14 10:23:32 AM
#11528   On our way to $4 and beyond. Enjoy ElChico 04/17/14 09:41:22 PM
#11527   at the moment his buy looks good 2.81 celtic 04/16/14 11:50:21 AM
#11526   Maybe Dr. Kim's not a great charting/CEO nowwhat2 04/16/14 10:25:16 AM
#11525   Yup you should just sell all you have gfunk15 04/16/14 10:22:41 AM
#11524   Game over (imho) nowwhat2 04/16/14 06:47:36 AM
#11523   I picked up shares yesterday at $2.66. I pmgtrader 04/15/14 08:32:08 PM
#11522   Congrats to us! stills999 04/15/14 03:12:01 PM
#11521   Picked up 3000 more shares @ 2.17-18. Thanks gfunk15 04/15/14 03:06:49 PM
#11520   Dr. Kim has bought more shares today, what adela 04/15/14 02:29:35 PM
#11519   I bought more @ $2.22 today.. I feel Xrouter 04/15/14 01:20:14 PM
#11518   This may help ease the pain,maybe. nypete 04/15/14 12:37:28 PM
#11517   Brutal for ino and oncs Fsa888 04/15/14 12:18:40 PM
#11516   Picked up some shares on the dip... don't stills999 04/15/14 12:09:52 PM
#11515   Great job Kim and BOD! cracity 04/15/14 11:55:58 AM
#11514   I'm out. I'll wait till sub $2s or 1s cracity 04/15/14 11:40:44 AM
#11513   It has been very silent from the INO pistol1p 04/15/14 11:31:01 AM
#11512   Jesus.... Dr. Kim needs to release news or gfunk15 04/15/14 10:29:34 AM
#11511   I can imagine how pissed those that bought cracity 04/15/14 10:20:18 AM
#11510   How far is everyone willing to let the cracity 04/15/14 09:55:12 AM
#11509   pistol, I believe Dr. Kim said at the twiz0019 04/15/14 07:38:20 AM
#11508   Future, I agree with your 2nd paragraph, regarding the pistol1p 04/15/14 12:45:09 AM
#11507   ROTATION. Pure and simple. Markets determine where the nypete 04/14/14 03:55:18 PM
#11506   Thanks pmg! EOM Green grine 04/14/14 03:01:29 PM
#11505   My guess is as good as yours. The pmgtrader 04/14/14 02:43:59 PM
#11504   Must have leaked!!!! Gee I should have Xrouter 04/14/14 02:43:30 PM
#11503   Not sure why biotech s have been being Green grine 04/14/14 02:35:55 PM
#11502   We are below average volume right now. If pmgtrader 04/14/14 01:54:58 PM
#11501   Has bad news on results leaked? cracity 04/14/14 01:52:25 PM
#11500   Opinions from longs please. I would appreciate any future1 04/13/14 07:18:49 PM
#11499   INO and ONCS are in biotech's sweet spot. Giddy-up! http://www.investmentu.com Ckbike 04/12/14 10:15:14 PM
#11498   Hate it when that happens! GLTU billmick11 04/11/14 10:52:01 AM
#11497   Dang, have a bid in for 2.81. Just cracity 04/11/14 09:50:42 AM
#11496   We've been fortunate to buy down at these mackwheaton 04/09/14 09:31:05 PM
#11495   OK , have my first long position .. Xrouter 04/09/14 08:25:28 PM
#11494   Hear The Shorts Knocking, But, I'm Staying Long Fsa888 04/09/14 01:05:38 PM
#11493   I had 334,000 shares of INO in the mackwheaton 04/08/14 11:40:34 PM
#11492   Mack, I definitely understand the feeling that biotechs may pistol1p 04/08/14 11:23:27 PM
#11491   Almost time to buy INO again. 136 04/08/14 09:30:30 PM
#11490   Today's price range did major technical damage to ringao 04/08/14 09:25:26 PM
#11489   Hey strik, once or twice a year my mackwheaton 04/08/14 05:09:33 PM
#11488   No doubt. may have to amend the RS cracity 04/08/14 04:27:52 PM
PostSubject